Search by Drug Name or NDC
NDC 68180-0830-73 AMABELZ 1; .5 mg/1; mg/1 Details
AMABELZ 1; .5 mg/1; mg/1
AMABELZ is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is ESTRADIOL; NORETHINDRONE.
Product Information
| NDC | 68180-0830 |
|---|---|
| Product ID | 68180-830_a6131391-5a54-479b-8a43-bda1a8af8730 |
| Associated GPIs | 24993002120310 |
| GCN Sequence Number | 040888 |
| GCN Sequence Number Description | estradiol/norethindrone acet TABLET 1 MG-0.5MG ORAL |
| HIC3 | G1A |
| HIC3 Description | ESTROGENIC AGENTS |
| GCN | 95046 |
| HICL Sequence Number | 007310 |
| HICL Sequence Number Description | ESTRADIOL/NORETHINDRONE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | AMABELZ |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | estradiol and norethindrone acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1; .5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ESTRADIOL; NORETHINDRONE |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Pharmaceutical Class | Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203339 |
| Listing Certified Through | 2022-12-31 |
Package
NDC 68180-0830-73 (68180083073)
| NDC Package Code | 68180-830-73 |
|---|---|
| Billing NDC | 68180083073 |
| Package | 3 POUCH in 1 CARTON (68180-830-73) / 1 BLISTER PACK in 1 POUCH (68180-830-71) / 28 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2020-10-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.86751 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | AMABELZ 1 MG-0.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis